<< Back To Home

Progress towards Polio Eradication in Nigeria

Tuesday, 5th of March 2019 Print



Progress towards Polio Eradication in Nigeria


Nigeria is one of the three remaining polio endemic countries in the world, and the only one in Africa. Here, from the WHO Bulletin and from BMC Public Health, is a treasure trove of articles on all aspects of polio eradication in the Federal Republic.


One common threat that runs through all successful polio programs is that of sustained high quality surveillance, augmented, in Nigeria, by AVADAR (item 6)


Good reading.


  1. Using the polio programme to deliver primary health care in Nigeria: implementation research.

Bawa S, McNab C, Nkwogu L, Braka F, Obinya E, Galway M, Mirelman AJ, Hammanyero KI, Safiyanu G, Chukwuji M, Ongwae K, Mkanda P, Corkum M, Hegg L, Tollefson D, Umar S, Audu S, Gunda H, Chinta M, Baptiste AEJ, Bagana M, Shuaib F.

Bull World Health Organ. 2019 Jan 1;97(1):24-32.




  1. Routine immunization community surveys as a tool for guiding program implementation in Kaduna state, Nigeria 2015-2016.

Nomhwange TI, Shuaib F, Braka F, Godwin S, Kariko U, Gregory U, Tegegne SG, Okposen B, Onoka C.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1313.




  1. Lessons learnt from implementing community engagement interventions in mobile hard-to-reach (HTR) projects in Nigeria, 2014-2015.

Hammanyero KI, Bawa S, Braka F, Bassey BE, Fatiregun A, Warigon C, Yehualashet YG, Tegene SG, Banda R, Korir C, Erbeto TB, Chukwuji M, Mkanda P, Adamu US, Nsubuga P.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1306.




  1. Distribution pattern of poliovirus potentially infectious materials in the phase 1b medical laboratories containment in conformity with the global action plan III.

Bassey BE, Braka F, Shuaib F, Banda R, Tegegne SG, Ticha JM, Abdullalhi WH, Kolawole OM, Kabir Y.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1319.




  1. Acute flaccid paralysis (AFP) surveillance intensification for polio certification in Kaduna state, Nigeria: lessons learnt, 2015-2016.

Umeh GC, Shuaib F, Musa A, Tegegne SG, Braka F, Mkanda P, Banda R, Adamu U, Nomhwange TI, Arenyeka E, Omoleke SA, Johnson TM, Craig K, Idris I, Iyal H, Sambo IG, Nsubuga P.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1310.




  1. AVADAR (Auto-Visual AFP Detection and Reporting): demonstration of a novel SMS-based smartphone application to improve acute flaccid paralysis (AFP) surveillance in Nigeria.

Shuaib FMB, Musa PF, Gashu ST, Onoka C, Ahmed SA, Bagana M, Galway M, Braka F, Muluh TJ, Banda R, Akpan G, Tunji A, Idris UK, Olusoga A, Briand P, Obiako N, Nebechukwu T, Mkanda P.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1305.




  1. Transboundary nomadic population movement: a potential for import-export of poliovirus.

Bawa S, Afolabi M, Abdelrahim K, Abba G, Ningi A, Tafida SY, Tegegne SG, Warigon C, Nomhwange T, Umar SA, Aregay A, Fanti A, Ahmed B, Nsubuga P, Adamu U, Braka F, Wondimagegnehu A, Shuaib F.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1316.




  1. Conduct of vaccination in hard-to-reach areas to address potential polio reservoir areas, 2014-2015.

Bawa S, Shuaib F, Saidu M, Ningi A, Abdullahi S, Abba B, Idowu A, Alkasim J, Hammanyero K, Warigon C, Tegegne SG, Banda R, Korir C, Yehualashet YG, Bedada T, Martin C, Nsubuga P, Adamu US, Okposen B, Braka F, Wondimagegnehu A, Vaz RG.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1312.




  1. Assessment of unmet needs to address noncompliant households during poliosupplemental immunization activities in Kaduna state, 2014-2016.

Iyal HA, Shuaib F, Dauda M, Suleiman A, Braka F, Tegegne SG, Nsubuga P, Nomhwange T, Yehualashet YG, Ishaku S, Warigon C, Zakari F, Umeh G, Samaila L, Abdullahi B, Hammanyero K, Dogo P, Adamu D, Vaz RG, Alemu W.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1309.




10. Impact of engaging security personnel on access and polio immunization outcomes in security-inaccessible areas in Borno state, Nigeria.

Nkwogu L, Shuaib F, Braka F, Mkanda P, Banda R, Korir C, Bawa S, Mele S, Saidu M, Mshelia H, Shettima A, Tegegne SG, Yehualashet YG, Adamu U, Nsubuga P, Vaz RG, Wondimagegnehu A.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1311.




11. Stopping circulatory vaccine-derived poliovirus in Kaduna state by scaling up special interventions in local government areas along rivers of interest- kamacha basin experience, 2013-2015.

Musa AI, Shuaib F, Braka F, Mkanda P, Banda R, Korir C, Tegegne SG, Abdullahi S, Umeh GC, Nomhwange TI, Iyal HA, Ishaku S, Adamu U, Damisa E, Bagana M, Gugong V, Balarabe H, Nsubuga P, Vaz RG.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1303.




12. Polio eradication in Nigeria: evaluation of the quality of acute flaccid paralysis surveillance documentation in Bauchi state, 2016.

Ningi AI, Shuaib F, Ibrahim LM, Saleh JA, Abdelrahim K, Bello IM, Abba B, Muluh TJ, Braka F, Tegegne SG, Wallah A, Korir C, Bawa S, Saidu M, Nsubuga P.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1307.




13. Profile of polio-compatible cases in Nigeria, 2006-2016.

Hamisu AW, Shuaib F, Johnson TM, Craig K, Fiona B, Banda R, Tegegne SG, Oyetunji A, Erbeto TB, Nsubuga P, Vaz RG, Muhamed AJG, Usman A.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1308.




14. Targeting the last polio sanctuaries with Directly Observed Oral Polio Vaccination (DOPV) in northern Nigeria, (2014-2016).

Korir C, Shuaib F, Adamu U, Bawa S, Musa A, Bashir A, Isiaka A, Ningi A, Warigon C, Richard B, Fiona B, Pascal M, Loveday N, Tegegne SG, Abdul-Aziz M, Suleiman A, Mohammed K, Corkum M, Onoka C, Nsubuga P, Yehualashet YG, Vaz RG, Alemu W.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1314.




15. Towards an effective poliovirus laboratory containment strategy in Nigeria.

Ticha JM, Matthew KO, Hamisu AW, Fiona B, Mkanda P, Nsubuga P, Tesfaye E, Craig K, Andrew E, Emelife O, Shuaib F, Folasade A, Adeniji J, Adamu U, Dallatu M, Oyeyinka G, Brown H, Nnamah N, Okwori J, Chinedu C, Anibijuwon I, Olubusuyi A, Emmanuel D, Bagana M, Baba M, Nicksy G, Banda R, Tegegne SG, Oyetunji A, Diop O, Tomori O, Vaz RG.

BMC Public Health. 2018 Dec 13;18(Suppl 4):1304.













Elimination of Epidemic Meningitis in the African Region: Progress and Challenges: 2010-2016.

Fall A, Bita AF, Lingani C, Djingarey M, Tevi-Benissan C, Preziosi MP, Ronveaux O, Mihigo R, Okeibunor J, Akanmori BD.

J Immunol Sci. 2018 Jul 2;Suppl:41-45.


Interventions to improve oral vaccine performance: a systematic review and meta-analysis.

Church JA, Parker EP, Kirkpatrick BD, Grassly NC, Prendergast AJ.

Lancet Infect Dis. 2019 Feb;19(2):203-214. doi: 10.1016/S1473-3099(18)30602-9. Epub 2019 Jan 30.


Identification and characterization of nonpolio enterovirus associated with nonpolio-acute flaccid paralysis in polio endemic state of Uttar Pradesh, Northern India.

Maan HS, Dhole TN, Chowdhary R.

PLoS One. 2019 Jan 30;14(1):e0208902. doi: 10.1371/journal.pone.0208902. eCollection 2019.


Resurgence of Vaccine-Preventable Diseases in Venezuela as a Regional Public Health Threat in the Americas.

Paniz-Mondolfi AE, Tami A, Grillet ME, Márquez M, Hernández-Villena J, Escalona-Rodríguez MA, Blohm GM, Mejías I, Urbina-Medina H, Rísquez A, Castro J, Carvajal A, Walter C, López MG, Schwabl P, Hernández-Castro L, Miles MA, Hotez PJ, Lednicky J, Morris JG Jr, Crainey J, Luz S, Ramírez JD, Sordillo E, Llewellyn M, Canache M, Araque M, Oletta J.

Emerg Infect Dis. 2019 Apr 17;25(4). doi: 10.3201/eid2504.181305. [Epub ahead of print]


Five-year experience of African Vaccination Week implemented by the WHO Regional Office.

Okeibunor J, Mihigo R, Anya B, Zawaira F.

J Immunol Sci. 2018 Aug 2;Suppl(2):10-16.


Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis.

Duintjer Tebbens RJ, Diop OM, Pallansch MA, Oberste MS, Thompson KM.

BMJ Open. 2019 Jan 21;9(1):e023290. doi: 10.1136/bmjopen-2018-023290.




First case in China of vaccine-associated poliomyelitis after sequential Inactivated and bivalent oral polio vaccination.

Peng X, Hu X, Salazar MA.

Vaccine. 2019 Jan 29;37(5):751-754. doi: 10.1016/j.vaccine.2018.12.022. Epub 2019 Jan 7.



Assessing the sensitivity of the polio environmental surveillance system.

Kroiss SJ, Ahmadzai M, Ahmed J, Alam MM, Chabot-Couture G, Famulare M, Mahamud A, McCarthy KA, Mercer LD, Muhammad S, Safdar RM, Sharif S, Shaukat S, Shukla H, Lyons H.

PLoS One. 2018 Dec 28;13(12):e0208336. doi: 10.1371/journal.pone.0208336. eCollection 2018.


Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants.

Church JA, Rukobo S, Govha M, Carmolli MP, Diehl SA, Chasekwa B, Ntozini R, Mutasa K, Humphrey JH, Kirkpatrick BD, Prendergast AJ.

Trans R Soc Trop Med Hyg. 2018 Dec 20. doi: 10.1093/trstmh/try126. [Epub ahead of print]


Cold chain and virus-free oral polio booster vaccine made in lettuce chloroplasts confers protection against all three poliovirus serotypes.

Daniell H, Rai V, Xiao Y.

Plant Biotechnol J. 2018 Dec 21. doi: 10.1111/pbi.13060. [Epub ahead of print]


Development of a thermostable microneedle patch for polio vaccination.

Kolluru C, Gomaa Y, Prausnitz MR.

Drug Deliv Transl Res. 2019 Feb;9(1):192-203. doi: 10.1007/s13346-018-00608-9.


Childhood vaccination in Kenya: socioeconomic determinants and disparities among the Somali ethnic community.

Masters NB, Wagner AL, Carlson BF, Muuo SW, Mutua MK, Boulton ML.

Int J Public Health. 2018 Dec 10. doi: 10.1007/s00038-018-1187-2. [Epub ahead of print]


Assessment of vaccination coverage of adolescents aged 16-18 years with an innovative electronic immunization record system.

Gault G, Fischer A, Nicand E, Burelle F, Burbaud A, Koeck JL.

Med Mal Infect. 2019 Feb;49(1):38-46. doi: 10.1016/j.medmal.2018.11.001. Epub 2018 Dec 4.


Evaluation of the acute flaccid paralysis (AFP) surveillance system in Mwenezi district, Masvingo, 2018: a descriptive study.

Muzondo M, Shamu A, Shambira G, Gombe NT, Juru TP, Tshimanga M.

BMC Res Notes. 2018 Dec 10;11(1):875. doi: 10.1186/s13104-018-3981-6.